Filter
209
Text search:
immunological
Featured
Recommendations
23
New Publications
44
Language
Document type
No document type
122
Guidelines
40
Studies & Reports
30
Manuals
8
Fact sheets
6
Training Material
2
Strategic & Response Plan
1
Countries / Regions
India
12
Tanzania
7
Global
7
Nigeria
5
Rwanda
5
Ethiopia
4
Uganda
4
Kenya
4
Latin America and the Carribbean
4
Congo, Democratic Republic of
3
South Africa
3
Brazil
3
Western and Central Europe
3
Africa
3
Sierra Leone
2
Ghana
2
Nepal
2
Pakistan
2
Afghanistan
2
Ukraine
2
South–East Asia Region
2
Eastern Europe
2
Russia
2
Liberia
1
USA
1
Philippines
1
Germany
1
Zambia
1
Syria
1
Cambodia
1
Indonesia
1
Bangladesh
1
Malawi
1
Central African Republic
1
Eswatini/ Swaziland
1
Colombia
1
Bolivia
1
Lesotho
1
Middle East and North Africa
1
Western Pacific Region
1
Venezuela
1
Estonia
1
Moldova
1
Authors & Publishers
Publication Years
Category
Countries
58
Clinical Guidelines
30
Public Health
10
Women & Child Health
10
Pharmacy & Technologies
7
Capacity Building
2
Key Resources
1
Toolboxes
HIV
40
TB
25
NTDs
20
COVID-19
19
Rapid Response
6
Mental Health
6
Planetary Health
6
Pharmacy
5
NCDs
5
Polio
4
Refugee
4
Disability
3
Ebola & Marburg
3
AMR
3
Caregiver
3
Malaria
2
Cholera
1
Natural Hazards
1
Research Article
Hindawi Publishing Corporation
AIDS Research and Treatment
Volume 2011, Article ID 621078, 7 pages doi:10.1155/2011/621078
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
This document focus on the direct consequences of the virus (morbidity and mortality) in specific populations and on the results of measures aimed at mitigating the spread of the virus, with indirect impacts on socio-economic conditions. In this complex scenario, the gender approach has not received
...
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
WHO/CDS/TB/99.272
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
Biodiversity and Health in the Face of Climate Change pp 47–66
This chapter reviews the emerging importance of pollen allergies in relation to ongoing climate change. Allergic diseases have been increasing in prevalence over the last decades, partly as the result of the impact of climate change.
...
Anxiety disorders
Chapter F.3
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
El VIH/sida, desconocido 30 años atrás, se ha constituido en un problema de salud
mundial de una magnitud sin precedentes, considerándose que aproximadamente 25 millones de personas han fallecido en todo el mundo a causa del VIH.
A 16-Year Cohort Analysis of Autism Spectrum Disorder-Associated Morbidity in a Pediatric Population
Front. Psychiatry, 29 November 2018 | https://doi.org/10.3389/fpsyt.2018.00635
20 February 2013
Update on 2004 Background Paper (Written by Saloni Tanna)
Priority Medicines for Europe and the World "A Public Health Approach to Innovation"
